Wordt geladen...
Personalized neoantigen-pulsed dendritic cell vaccines show superior immunogenicity to neoantigen-adjuvant vaccines in mouse tumor models
Development of personalized cancer vaccines based on neoantigens has become a new direction in cancer immunotherapy. Two forms of cancer vaccines have been widely studied: tumor-associated antigen (including proteins, peptides, or tumor lysates)-pulsed dendritic cell (DC) vaccines and protein- or pe...
Bewaard in:
| Gepubliceerd in: | Cancer Immunol Immunother |
|---|---|
| Hoofdauteurs: | , , , , , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Springer Berlin Heidelberg
2019
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6949210/ https://ncbi.nlm.nih.gov/pubmed/31807878 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00262-019-02448-z |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|